Dr. Bunick examines the ongoing discussion surrounding benzene contamination concerns in benzoyl peroxide (BPO) products, addressing questions about product safety, regulatory oversight, and best practices
Dr. Lio discusses the complex relationship between diet and **Atopic Dermatitis (AD), addressing common patient questions, misconceptions, and concerns regarding dietary modifications. His presentation emphasizes
Dr. Graber reviews emerging evidence supporting the use of energy-based devices for the treatment of Acne Vulgaris and Rosacea, highlighting how advances in laser and
Dr. Daveluy discusses practical techniques and clinical considerations for using cryoinsufflation in the treatment of Hidradenitis Suppurativa (HS). His presentation provides guidance on incorporating this
Dr. Lio discusses strategies for addressing chronic itch (pruritus) in patients undergoing treatment for non-dermatologic cancers, a symptom that can significantly affect comfort, sleep quality,
Dr. Daveluy explores the important relationship between nutrition and dermatologic therapies, discussing how dietary choices can influence the effectiveness, absorption, and side effect profiles of
Dr. Jennifer Hsiao shares emerging strategies for treating recalcitrant hidradenitis suppurativa when standard therapies fail. Topics Covered: Management of treatment-resistant HS Emerging therapies and clinical
Dr. Bunick provides a comprehensive review of the evolving role of antibiotics in treating Acne Vulgaris and Rosacea, examining current evidence on their benefits, limitations,
Dr. Swanson highlights key developments presented at the AAD 2025 Annual Meeting, providing an overview of emerging therapies, clinical research, and treatment advances across several
Dr. Chovatiya highlights key insights from a symposium presented at the AAD 2025 Annual Meeting, focusing on the diagnosis and management of **Chronic Hand Eczema
Drawing from his presentation at the AAD 2025 Annual Meeting, Dr. Rosmarin reviews practical strategies for maximizing treatment outcomes with Ruxolitinib> cream in patients with
Dr. Hamzavi reviews the role of surgical intervention in the management of Vitiligo, focusing on identifying appropriate candidates and outlining the available procedural techniques for
Dr. Hamzavi reviews key takeaways from his presentation during the AAD 2025 Annual Meeting session on surgical management of **Hidradenitis Suppurativa (HS). His discussion focuses
Drawing from his presentation at the AAD 2025 Annual Meeting, Dr. Drucker reviews findings from a network meta-analysis comparing systemic therapies for Atopic Dermatitis. His
In this recap of his presentation at the AAD 2025 Annual Meeting, Dr. Chovatiya examines the social and structural disparities that influence the diagnosis, treatment,
Dr. Gooderham reviews the evolving role of JAK inhibitors in the treatment of Psoriasis, focusing on how different mechanisms of JAK inhibition may influence therapeutic
Drawing from his presentation at the AAD 2025 Annual Meeting, Dr. Seneschal reviews the immune mechanisms underlying Vitiligo and explains why long-term maintenance therapy is
